Skip to main content

Avinza News (Page 2)

FDA Medwatch Alert: Endo Pharmaceuticals Opiate Products by Novartis Consumer Health: Public Health Advisory - Potential Safety Risk

Including the following products: Opana ER (oxymorphone hydrochloride) Extended-Release Tablets CII Opana (oxymorphone hydrochloride) CII Oxymorphone hydrochloride Tablets CII PERCOCET (oxycodone...

FDA Medwatch Alert: Avinza (morphine sulfate extended-release

[Posted 11/03/2005] Ligand Pharmaceuticals Inc. and FDA notified healthcare professionals of revisions to BOXED WARNING, WARNINGS, PRECAUTIONS, CLINICAL PHARMACOLOGY, and DOSAGE AND ADMINISTRATION...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Chronic Pain, Pain

Avinza patient information at Drugs.com